Thiogenesis Therapeutics Corp

NEW
FRA:Q8M (Canada)  
€ 0.29 (0%) Sep 18
At Loss
P/B:
5.31
Market Cap:
€ 22.23M ($ 25.53M)
Enterprise V:
€ 17.70M ($ 20.33M)
Volume:
3.00K
Avg Vol (2M):
10.00K
Trade In:
Volume:
3.00K
At Loss

Thiogenesis Therapeutics Corp (FRA:Q8M) Dividend

Thiogenesis Therapeutics Corp (FRA:Q8M) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -22.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:Q8M Dividend

Does Thiogenesis Therapeutics Corp (FRA:Q8M) pay a dividend?

Thiogenesis Therapeutics Corp (FRA:Q8M) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Thiogenesis Therapeutics Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Thiogenesis Therapeutics Corp has returned capital to shareholders via buybacks at a rate of -22.9% over the past 3 years.

What are dividend-paying alternatives to Thiogenesis Therapeutics Corp?

For dividend-paying alternatives in Thiogenesis Therapeutics Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.